Theoretical study on the design of allosteric inhibitors of diabetes associated protein PTP1B
The protein tyrosine phosphatase 1B (PTP1B) is a critical therapeutic target for type 2 diabetes mellitus (T2DM). Many PTP1B inhibitors have been reported, however, most of them lack high specificity and have adverse effects. Designing effective PTP1B inhibitors requires understanding the molecular...
Saved in:
Main Authors: | Jiuyu Zhan (Author), Zhenyang Liu (Author), Hongwei Gao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design and synthesis of tricyclic terpenoid derivatives as novel PTP1B inhibitors with improved pharmacological property and in vivo antihyperglycaemic efficacy
by: Lingling Yang, et al.
Published: (2020) -
Identification of flavonolignans from Silybum marianum seeds as allosteric protein tyrosine phosphatase 1B inhibitors
by: Ningbo Qin, et al.
Published: (2018) -
Novel benzamido derivatives as PTP1B inhibitors with anti-hyperglycemic and lipid-lowering efficacy
by: Yanbo Tang, et al.
Published: (2018) -
Inhibitors of recombinant protein-tyrosine phosphatase 1B (PTP1B) from Khaya senegalensis: Towards a strategic target for therapeutic intervention in trypanosomiasis
by: Fatima Amin Adamude, et al.
Published: (2022) -
The importance of including the C-terminal domain of PTP1B1-400 to identify potential antidiabetic inhibitors
by: Andrea Coronell-Tovar, et al.
Published: (2023)